肺癌的CAR-T:挑战和创新
Lucia Trudu1, Giulia Rovesti1, Giovanni Neri2
1Laboratory of Cellular Therapy, Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, Modena 41124, Italy; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena 41124, Italy; Division of Oncology, Department of Oncology and Hematology, University-Hospital of Modena and Reggio Emilia, Modena 41124, Italy.
Lung cancer (Amsterdam, Netherlands)
|August 16, 2025
概括
化学抗原受体 (CAR) T细胞疗法对肺癌 (LC) 治疗有希望,克服了抗原选择和瘤微环境等挑战. 目前正在进行的研究旨在解释CAR T细胞对这种致命疾病的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 肺癌 (LC) 仍然是全球癌症死亡的主要原因.
- 包括免疫疗法在内的当前治疗方法在许多患者中显示出有限的疗效.
- 即使使用先进疗法,复发也很常见.
研究的目的:
- 审查化学抗原受体 (CAR) T 细胞治疗在治疗肺癌中的新兴作用.
- 突出挑战和正在探索的新策略,用于像LC这样的固体瘤的CAR T细胞治疗.
- 评估CAR T细胞在改善肺癌患者治疗结果方面的潜力.
主要方法:
- 对肺癌CAR T细胞治疗的临床前和临床研究的综述.
- 对抗原选择,瘤微环境和CAR T细胞持久性挑战的分析.
- 探索新的方法和组合策略,以提高CAR T细胞的疗效.
主要成果:
- 虽然CAR T细胞疗法在血液癌症中取得了成功,但在肺癌等固体瘤中面临重大障碍.
- 挑战包括识别合适的瘤抗原,克服免疫抑制瘤微环境,并确保T细胞的持久性.
- 许多研究正在调查各种抗原和创新的策略来解决这些局限性.
结论:
- 尽管存在挑战,但CAR T细胞疗法对肺癌治疗具有重大前景.
- 目前正在进行的研究和新的策略正在为临床翻译铺平道路.
- 预计CAR T细胞疗法将成为肺癌治疗范式的宝贵补充.
相关概念视频
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K